Frequent blood draws are a dreaded part of IVF. At Columbia’s fertility center, blood can now be drawn painlessly at home, thanks to an innovative laboratory test developed by center staff.
A study led by Columbia obstetricians has shown that a new device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in a wide range of patients.
The center at Columbia University Irving Medical Center, funded by the NIH, will support research to reduce pregnancy-related morbidity and mortality while promoting equity.
The Mothers Center is a new space that will provide comprehensive, multidisciplinary care—focused on the mother—before, during, and after a high-risk pregnancy.
RhoGAM, a drug developed in the 1960s by Columbia University physicians, prevents one of the most severe and devastating diseases affecting fetuses and newborn babies and is still in use today.
Twin pregnancies in women 35 and older do not carry substantially higher risks of preterm birth, fetal death, or infant death compared with twin pregnancies in younger women.
Sexual reproduction may have never evolved if organisms hadn’t developed a way to restrain the immune system during fertilization, according to a new CUMC study.
The center provides personalized medical care for women at high risk for preterm birth and conducts research to find better ways to prevent preterm birth.